%0 Journal Article
%T Small Cell Lung Cancer-An Update on Chemotherapy Resistance.
%A Ying Q
%A Fan R
%A Shen Y
%A Chen B
%A Zhang J
%A Li Q
%A Shi X
%J Curr Treat Options Oncol
%V 25
%N 8
%D 2024 Aug 27
%M 39066852
%F 5.08
%R 10.1007/s11864-024-01245-w
%X <B>UNASSIGNED: </B>Compared to other types of lung cancer, small cell lung cancer (SCLC) exhibits aggressive characteristics that promote drug resistance. Despite platinum-etoposide chemotherapy combined with immunotherapy being the current standard treatment, the rapid development of drug resistance has led to unsatisfactory clinical outcomes. This review focuses on the mechanisms contributing to the chemotherapy resistance phenotype in SCLC, such as increased intra-tumoral heterogeneity, alterations in the tumor microenvironment, changes in cellular metabolism, and dysregulation of apoptotic pathways. A comprehensive understanding of these drug resistance mechanisms in SCLC is imperative for ushering in a new era in cancer research, which will promise revolutionary advancements in cancer diagnosis and treatment methodologies.